Table 2.
Clinicopathological and morphological characteristics of neuroendocrine tumor (24 cases) and solid-pseudopapillary neoplasm (6 cases)
| Case | Age | Sex | Clinical findings | Tumor location | Operation | Diameter (cm) | Mitotic | Ki-67 | Grade | Solid or | PP |
| (yr) | count | (%) | for NETs | Cystic | pattern | ||||||
| NET-1 | 31 | F | MEN1 | H | PD | 4.5 | 0 | 0 | 1 | Solid and Cystic | Absent |
| NET-2 | 57 | F | MEN1 | H, T | EC, DP | 5.3 | 0 | 1 | 1 | Solid | Absent |
| NET-3 | 51 | F | MEN1 | H, B, T, L | EC, DP, LR | 6.0 | 0 | 0 | 1 | Solid | Absent |
| NET-4 | 45 | F | MEN1 | B, T | DP | 1.4 | 0 | 0 | 1 | Solid and Cystic | Absent |
| NET-5 | 42 | F | insulinoma | B | EC | 1.0 | 0 | 0 | 1 | Solid | Absent |
| NET-6 | 62 | F | insulinoma | H | EC | 1.2 | 0 | 0 | 1 | Solid | Absent |
| NET-7 | 73 | M | insulinoma | H | PD | 1.5 | 0 | 0 | 1 | Solid | Absent |
| NET-8 | 74 | F | insulinoma | T | DP | 1.0 | 0 | 0 | 1 | Solid | Absent |
| NET-9 | 67 | M | insulinoma | B | EC | 0.9 | 1 | 0 | 1 | Solid | Absent |
| NET-10 | 51 | F | insulinoma | B | MP | 1.1 | 7 | 2 | 2 | Solid | Absent |
| NET-11 | 45 | M | H | EC | 2.3 | 0 | 0 | 1 | Solid | Absent | |
| NET-12 | 68 | F | H | EC | 0.5 | 0 | 0 | 1 | Solid | Absent | |
| NET-13 | 77 | M | T | DP | 0.9 | 1 | 0 | 1 | Solid | Absent | |
| NET-14 | 57 | M | H | PD | 1.5 | 1 | 0 | 1 | Solid | Absent | |
| NET-15 | 45 | M | H | EC | 0.9 | 2 | 0 | 1 | Solid | Absent | |
| NET-16 | 51 | F | H | PD | 2.5 | 0 | 1 | 1 | Solid | Absent | |
| NET-17 | 59 | M | H | MP | 1.8 | 1 | 1 | 1 | Solid | Absent | |
| NET-18 | 59 | F | T | EC | 2.3 | 1 | 1 | 1 | Solid and Cystic | Absent | |
| NET-19 | 40 | F | T | DP | 3.3 | 0 | 4 | 2 | Solid and Cystic | Absent | |
| NET-20 | 53 | M | T | DP | 5.5 | 2 | 3 | 2 | Solid | Absent | |
| NET-21 | 39 | M | H, B, T | TP | 16 | 3 | 0 | 2 | Solid | Absent | |
| NET-22 | 51 | M | H | PD | 7.0 | 7 | 4 | 2 | Solid | Absent | |
| NET-23 | 58 | F | B | EC | 1.8 | 1 | 0 | 1 | Solid | Absent | |
| NET-24 | 32 | M | H | PD | 2.3 | 0 | 0 | 1 | Solid | Absent | |
| SPN-1 | 26 | F | H | EC | 8.5 | 0 | 0 | - | Solid and Cystic | Present | |
| SPN-2 | 34 | F | T | DP | 7.0 | 1 | 1 | - | Solid and Cystic | Present | |
| SPN-3 | 20 | F | T | DP | 7.5 | 0 | 0 | - | Solid and Cystic | Present | |
| SPN-4 | 23 | F | T | DP | 13 | 0 | 0 | - | Solid and Cystic | Present | |
| SPN-5 | 43 | F | B | MP | 3.8 | 0 | 0 | - | Solid and Cystic | Present | |
| SPN-6 | 27 | M | T | DP | 4.3 | 0 | 0 | - | Solid and Cystic | Present |
NET: Neuroendocrine tumor; SPN: Solid-pseudopapillary neoplasm; MEN: Multiple endocrine neoplasia; H: Pancreatic head; B: Pancreatic body; T: Pancreatic tail; L: Liver; PD: Pancreatoduodenectomy; MP: Middle pancreatectomy; DP: Distal pancreatectomy: TP: Total pancreatectomy; EC: Enucleation; LR: Liver resection; PP: Pattern pseudopapillary pattern; -: Not assessed.